SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reporting infections in clinical trials of patients with haematological malignancies
5 references·0 citing·23 second hopsampled
Reporting infections in clinical trials of patients with haematological malignancies (2019)Reporting infections in clinical trials o…Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review (2013)Adherence to CONSORT Adverse …The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals (2010)The quality of safety reporti…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004)Better Reporting of Harms in …Reporting results of cancer treatment (1981)The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2008)Improving the Quality of Reporting of Randomized Controlled Trials (1996)Meta‐Analysis in Medical Research (2005)Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review (2016)Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms (2017)Improving the Quality of Reporting of Randomized Controlled Trials (1996)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy (2014)Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review (2014)Scoping review on interventions to improve adherence to reporting guidelines in health research (2019)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Cochrane Handbook for Systematic Reviews of Interventions (2008)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Rayyan—a web and mobile app for systematic reviews (2016)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.48,853 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement19,875 cited
  • 2004Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement1,591 cited
  • 2013Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review132 cited
  • 2010The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals84 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work